Scaling production of adeno-associated virus vectors remains a key barrier [...]

Allucent has appointed new therapeutic strategy leaders across key disease [...]

Sartorius has launched a new platform designed to address manufacturing [...]

Scribe Therapeutics has achieved a second success milestone in its [...]

SynGenSys has launched Liver.SET, a library of liver-specific synthetic promoters [...]

NanoSyrinx has appointed Thomas Farrell as chief executive officer and [...]

eXmoor Pharma has formed a strategic collaboration with University College [...]

Lonza has signed an agreement to acquire Redberry, a French [...]

BBG Advanced Therapies (BBGAT), a subsidiary of BioBridge Global and [...]

Vitalant has launched a national hub-and-spoke model to expand patient [...]